The ability to predict well in advance could allow for early intervention and prevention. Researchers have discovered five ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

A new study reveals how a critical imbalance in bile acids—the substances made by the liver that help digest fats—can trigger ...

In recent years our traditional understanding of both macrophages and neutrophils has been greatly challenged. Previously thought to promote inflammatory ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern, with an estimated prevalence of around 25% worldwide. This chronic liver condition is characterized ...

Research in Mayo Clinic's Liver Disease Immunobiology Lab led by Petra Hirsova, Pharm.D., Ph.D., focuses on metabolic dysfunction-associated steatohepatitis.

Scientists have identified five specific blood proteins that can accurately predict a person's risk for developing a serious ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Multi-modal data integration of single-nuclei RNA and ATAC sequencing with spatial transcriptomics, provides new molecular insights into gene regulatory networks driving cell state transitions in ...

While there is a relatively good understanding of the cell types that are highly differentiated, such as water-conducting xylem and sugar-conducting phloem, the morphologically similar parenchyma ...